NASDAQ: CHYM
Chime Financial Inc Stock Forecast, Predictions & Price Target

Analyst price target for CHYM

Based on 14 analysts offering 12 month price targets for Chime Financial Inc

Min Forecast
$17.00-30.95%
Avg Forecast
$33.14+34.62%
Max Forecast
$40.00+62.47%

Should I buy or sell CHYM stock?

Based on 14 analysts offering ratings for Chime Financial Inc.

Strong Buy
Strong Buy
7 analysts 50%
Buy
3 analysts 21.43%
Hold
4 analysts 28.57%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CHYM's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates CHYM as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their CHYM stock forecasts and price targets.

CHYM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-11
lockedlocked$00.00+00.00%2025-12-01
lockedlocked$00.00+00.00%2025-11-06
lockedlocked$00.00+00.00%2025-11-06
lockedlocked$00.00+00.00%2025-11-06
Jefferies
Top 18%
83
HoldInitiates Coverage On$17.00-30.95%2025-11-03
Canaccord Genuity
Top 1%
100
Strong BuyMaintains$40.00+62.47%2025-10-30
Keefe, Bruyette & Woods
Top 17%
84
BuyMaintains$35.00+42.16%2025-10-01
Deutsche Bank
Bottom 9%
9
HoldReinstates$35.00+42.16%2025-07-17
Anonymous
Wolfe Research
BuyInitiates Coverage On$38.00+54.35%2025-07-07

1 of 2

Forecast return on equity

Is CHYM forecast to generate an efficient return?

Company
N/A
Industry
88%
Market
229.15%

Forecast return on assets

Is CHYM forecast to generate an efficient return on assets?

Company
N/A
Industry
41.57%

CHYM earnings per share forecast

What is CHYM's earnings per share in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
-$4.61
Avg 2 year Forecast
-$0.05
Avg 3 year Forecast
$0.37

CHYM revenue forecast

What is CHYM's revenue in the next 3 years based on estimates from 16 analysts?

Avg 1 year Forecast
$2.2B
Avg 2 year Forecast
$2.7B
Avg 3 year Forecast
$3.1B

CHYM vs App Stocks

TickerPricePrice TargetUp/downsideConsensus
CHYM$24.62$33.14+34.62%Strong Buy
PAYC$162.81$224.78+38.06%Buy
TTAN$103.11$137.92+33.76%Strong Buy
DUOL$185.97$314.29+69.00%Buy
PEGA$58.38$71.78+22.95%Strong Buy

Chime Financial Stock Forecast FAQ

Is Chime Financial Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 14 Wall Street analysts covering (NASDAQ: CHYM) stock is to Strong Buy CHYM stock.

Out of 14 analysts, 7 (50%) are recommending CHYM as a Strong Buy, 3 (21.43%) are recommending CHYM as a Buy, 4 (28.57%) are recommending CHYM as a Hold, 0 (0%) are recommending CHYM as a Sell, and 0 (0%) are recommending CHYM as a Strong Sell.

If you're new to stock investing, here's how to buy Chime Financial stock.

What is CHYM's earnings growth forecast for 2025-2027?

(NASDAQ: CHYM) Chime Financial's forecast annual earnings growth rate of N/A is not forecast to beat the US Software - Application industry's average forecast earnings growth rate of 24.09%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.92%.

Chime Financial's earnings in 2025 is N/A.On average, 12 Wall Street analysts forecast CHYM's earnings for 2025 to be -$1,725,043,999, with the lowest CHYM earnings forecast at -$2,698,085,233, and the highest CHYM earnings forecast at -$1,093,393,141. On average, 12 Wall Street analysts forecast CHYM's earnings for 2026 to be -$18,167,032, with the lowest CHYM earnings forecast at -$102,784,199, and the highest CHYM earnings forecast at $188,787,305.

In 2027, CHYM is forecast to generate $137,058,085 in earnings, with the lowest earnings forecast at $44,050,371 and the highest earnings forecast at $350,043,128.

What is CHYM's revenue growth forecast for 2025-2027?

(NASDAQ: CHYM) Chime Financial's forecast annual revenue growth rate of N/A is not forecast to beat the US Software - Application industry's average forecast revenue growth rate of 12.56%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.58%.

Chime Financial's revenue in 2025 is N/A.On average, 16 Wall Street analysts forecast CHYM's revenue for 2025 to be $828,566,505,032, with the lowest CHYM revenue forecast at $794,854,486,292, and the highest CHYM revenue forecast at $854,786,964,052. On average, 16 Wall Street analysts forecast CHYM's revenue for 2026 to be $995,628,286,788, with the lowest CHYM revenue forecast at $929,327,983,266, and the highest CHYM revenue forecast at $1,056,684,498,506.

In 2027, CHYM is forecast to generate $1,172,054,518,194 in revenue, with the lowest revenue forecast at $1,065,674,370,170 and the highest revenue forecast at $1,294,916,097,602.

What is CHYM's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: CHYM) forecast ROA is N/A, which is lower than the forecast US Software - Application industry average of 41.57%.

What is CHYM's Price Target?

According to 14 Wall Street analysts that have issued a 1 year CHYM price target, the average CHYM price target is $33.14, with the highest CHYM stock price forecast at $40.00 and the lowest CHYM stock price forecast at $17.00.

On average, Wall Street analysts predict that Chime Financial's share price could reach $33.14 by Dec 11, 2026. The average Chime Financial stock price prediction forecasts a potential upside of 34.62% from the current CHYM share price of $24.62.

What is CHYM's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: CHYM) Chime Financial's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that CHYM's EPS will be -$4.61 for 2025, with the lowest EPS forecast at -$7.20, and the highest EPS forecast at -$2.92. On average, analysts forecast that CHYM's EPS will be -$0.05 for 2026, with the lowest EPS forecast at -$0.27, and the highest EPS forecast at $0.50. In 2027, CHYM's EPS is forecast to hit $0.37 (min: $0.12, max: $0.93).

What is CHYM's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: CHYM) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.